Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Sep;101(1):157–165. doi: 10.1111/j.1476-5381.1990.tb12106.x

Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.

T Yanagisawa 1, T Teshigawara 1, N Taira 1
PMCID: PMC1917636  PMID: 2149290

Abstract

1. In order to investigate the vasodilator mechanisms of the K+ channel openers, cromakalim, pinacidil and nicorandil, we measured changes in cytoplasmic Ca2+ concentration [( Ca2+]i) simultaneously with force by a microfluorimetric method using fura-2, a calcium indicator, in canine coronary arterial smooth muscle cells. 2. The three K+ channel openers all produced a concentration-dependent reduction of [Ca2+]i in 5 and 30 mM KCl physiological salt solution (PSS) but failed to affect [Ca2+]i in 45 and 90 mM KCl-PSS. 3. Cromakalim only partly inhibited (-45%) the 30 mM KCl-induced contractures, whereas pinacidil and nicorandil nearly abolished contractions produced by 45 mM, 90 mM and 30 mM KCl-PSS. 4. Tetrabutylammonium (TBA), a nonselective K+ channel blocker, or glibenclamide, a supposed adenosine 5'-triphosphate (ATP)-sensitive K+ channel blocker, abolished the reduction of [Ca2+]i caused by the three K+ channel openers and the relaxant effect of cromakalim, whereas they only slightly attenuated the relaxant effects of pinacidil and nicorandil. 5. The increase in [Ca2+]i produced by 45 or 90 mM KCl-PSS in the presence of pinacidil or nicorandil was abolished by 10(-5) M verapamil, indicating that the increase in [Ca2+]i was caused by the influx of extracellular Ca2+ and that pinacidil and nicorandil did not affect the voltage-dependent Ca2+ channel directly. 6. The [Ca2+]i-force relationship in the presence of cromakalim was not distinguishable from that of control. 7. The [Ca2+]i-force curve was shifted to the right by pinacidil and nicorandil.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrigoni-Martelli E., Nielsen C. K., Olsen U. B., Petersen H. J. N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator. Experientia. 1980 Apr 15;36(4):445–447. doi: 10.1007/BF01975139. [DOI] [PubMed] [Google Scholar]
  2. Bray K. M., Newgreen D. T., Small R. C., Southerton J. S., Taylor S. G., Weir S. W., Weston A. H. Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol. 1987 Jun;91(2):421–429. doi: 10.1111/j.1476-5381.1987.tb10297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bruschi G., Bruschi M. E., Regolisti G., Borghetti A. Myoplasmic Ca2+-force relationship studied with fura-2 during stimulation of rat aortic smooth muscle. Am J Physiol. 1988 May;254(5 Pt 2):H840–H854. doi: 10.1152/ajpheart.1988.254.5.H840. [DOI] [PubMed] [Google Scholar]
  4. Buckingham R. E., Hamilton T. C., Howlett D. R., Mootoo S., Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol. 1989 May;97(1):57–64. doi: 10.1111/j.1476-5381.1989.tb11923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Castle N. A., Haylett D. G., Jenkinson D. H. Toxins in the characterization of potassium channels. Trends Neurosci. 1989 Feb;12(2):59–65. doi: 10.1016/0166-2236(89)90137-9. [DOI] [PubMed] [Google Scholar]
  6. Cook N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988 Jan;9(1):21–28. doi: 10.1016/0165-6147(88)90238-6. [DOI] [PubMed] [Google Scholar]
  7. Eltze M. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eur J Pharmacol. 1989 Jun 20;165(2-3):231–239. doi: 10.1016/0014-2999(89)90717-6. [DOI] [PubMed] [Google Scholar]
  8. Endoh M., Taira N. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 1983 May;322(4):319–321. doi: 10.1007/BF00508349. [DOI] [PubMed] [Google Scholar]
  9. Escande D., Thuringer D., Leguern S., Cavero I. The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. Biochem Biophys Res Commun. 1988 Jul 29;154(2):620–625. doi: 10.1016/0006-291x(88)90184-2. [DOI] [PubMed] [Google Scholar]
  10. Fosset M., De Weille J. R., Green R. D., Schmid-Antomarchi H., Lazdunski M. Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels. J Biol Chem. 1988 Jun 15;263(17):7933–7936. [PubMed] [Google Scholar]
  11. Furukawa K., Itoh T., Kajiwara M., Kitamura K., Suzuki H., Ito Y., Kuriyama H. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther. 1981 Jul;218(1):248–259. [PubMed] [Google Scholar]
  12. Godfraind T., Miller R., Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986 Dec;38(4):321–416. [PubMed] [Google Scholar]
  13. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  14. Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Himpens B., Somlyo A. P. Free-calcium and force transients during depolarization and pharmacomechanical coupling in guinea-pig smooth muscle. J Physiol. 1988 Jan;395:507–530. doi: 10.1113/jphysiol.1988.sp016932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holzmann S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol. 1983 May-Jun;5(3):364–370. doi: 10.1097/00005344-198305000-00004. [DOI] [PubMed] [Google Scholar]
  17. Itoh T., Kanmura Y., Kuriyama H., Sasaguri T. Nitroglycerine- and isoprenaline-induced vasodilatation: assessment from the actions of cyclic nucleotides. Br J Pharmacol. 1985 Feb;84(2):393–406. doi: 10.1111/j.1476-5381.1985.tb12923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kamm K. E., Stull J. T. Regulation of smooth muscle contractile elements by second messengers. Annu Rev Physiol. 1989;51:299–313. doi: 10.1146/annurev.ph.51.030189.001503. [DOI] [PubMed] [Google Scholar]
  19. Karaki H. Ca2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol Sci. 1989 Aug;10(8):320–325. doi: 10.1016/0165-6147(89)90066-7. [DOI] [PubMed] [Google Scholar]
  20. Kauffman R. F., Schenck K. W., Conery B. G., Cohen M. L. Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1195–1200. doi: 10.1097/00005344-198611000-00015. [DOI] [PubMed] [Google Scholar]
  21. Ozaki H., Sato K., Satoh T., Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn J Pharmacol. 1987 Nov;45(3):429–433. doi: 10.1254/jjp.45.429. [DOI] [PubMed] [Google Scholar]
  22. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  23. Pfitzer G., Hofmann F., DiSalvo J., Rüegg J. C. cGMP and cAMP inhibit tension development in skinned coronary arteries. Pflugers Arch. 1984 Jul;401(3):277–280. doi: 10.1007/BF00582596. [DOI] [PubMed] [Google Scholar]
  24. Poenie M., Alderton J., Steinhardt R., Tsien R. Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. Science. 1986 Aug 22;233(4766):886–889. doi: 10.1126/science.3755550. [DOI] [PubMed] [Google Scholar]
  25. Quast U., Cook N. S. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther. 1989 Jul;250(1):261–271. [PubMed] [Google Scholar]
  26. Sanguinetti M. C., Scott A. L., Zingaro G. J., Siegl P. K. BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8360–8364. doi: 10.1073/pnas.85.21.8360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Standen N. B., Quayle J. M., Davies N. W., Brayden J. E., Huang Y., Nelson M. T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989 Jul 14;245(4914):177–180. doi: 10.1126/science.2501869. [DOI] [PubMed] [Google Scholar]
  28. Stanfield P. R. Tetraethylammonium ions and the potassium permeability of excitable cells. Rev Physiol Biochem Pharmacol. 1983;97:1–67. doi: 10.1007/BFb0035345. [DOI] [PubMed] [Google Scholar]
  29. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989 Jun 20;63(21):18J–24J. doi: 10.1016/0002-9149(89)90200-2. [DOI] [PubMed] [Google Scholar]
  30. Taira N., Satoh K., Yanagisawa T., Imai Y., Hiwatari M. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75). Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):301–316. doi: 10.1111/j.1440-1681.1979.tb01252.x. [DOI] [PubMed] [Google Scholar]
  31. Waldman S. A., Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987 Sep;39(3):163–196. [PubMed] [Google Scholar]
  32. Weir S. W., Weston A. H. Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol. 1986 May;88(1):113–120. doi: 10.1111/j.1476-5381.1986.tb09477.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Weir S. W., Weston A. H. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol. 1986 May;88(1):121–128. doi: 10.1111/j.1476-5381.1986.tb09478.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weston A. H. Smooth muscle K+ channel openers; their pharmacology and clinical potential. Pflugers Arch. 1989;414 (Suppl 1):S99–105. doi: 10.1007/BF00582256. [DOI] [PubMed] [Google Scholar]
  35. Weston A. H. Some effects of nicorandil on the smooth muscles of the rat and guinea pig. J Cardiovasc Pharmacol. 1987;10 (Suppl 8):S56–S61. [PubMed] [Google Scholar]
  36. Wilson C., Coldwell M. C., Howlett D. R., Cooper S. M., Hamilton T. C. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Eur J Pharmacol. 1988 Aug 2;152(3):331–339. doi: 10.1016/0014-2999(88)90728-5. [DOI] [PubMed] [Google Scholar]
  37. Winquist R. J., Heaney L. A., Wallace A. A., Baskin E. P., Stein R. B., Garcia M. L., Kaczorowski G. J. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther. 1989 Jan;248(1):149–156. [PubMed] [Google Scholar]
  38. Yanagisawa T., Hashimoto H., Taira N. Interaction of potassium channel openers and blockers in canine atrial muscle. Br J Pharmacol. 1989 Jul;97(3):753–762. doi: 10.1111/j.1476-5381.1989.tb12013.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yanagisawa T., Hashimoto H., Taira N. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle. Br J Pharmacol. 1988 Oct;95(2):393–398. doi: 10.1111/j.1476-5381.1988.tb11658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yanagisawa T., Kawada M., Taira N. Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2. Br J Pharmacol. 1989 Oct;98(2):469–482. doi: 10.1111/j.1476-5381.1989.tb12620.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yanagisawa T., Satoh K., Taira N. Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75). Jpn J Pharmacol. 1979 Oct;29(5):687–694. doi: 10.1254/jjp.29.687. [DOI] [PubMed] [Google Scholar]
  42. Yanagisawa T., Taira N. Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance. Naunyn Schmiedebergs Arch Pharmacol. 1980 May;312(1):69–76. doi: 10.1007/BF00502577. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES